— Know what they know.
Not Investment Advice

INGN

Inogen, Inc.
1W: +5.5% 1M: +8.2% 3M: -2.7% YTD: -2.0% 1Y: -10.3% 3Y: -51.3% 5Y: -87.2%
$6.50
+0.08 (+1.25%)
After Hours: $6.60 (+0.10, +1.54%)
NASDAQ · Healthcare · Medical - Devices · $177.0M · Alpha Radar Buy · Power 63
Smart Money Score
Moderate 50
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$177.0M
52W Range5.34-9.13
Volume167,548
Avg Volume269,372
Beta1.78
Dividend
Analyst Ratings
6 Buy 4 Hold 1 Sell
Consensus Buy
Company Info
CEOKevin R. Smith
Employees766
SectorHealthcare
IndustryMedical - Devices
IPO Date2014-02-14
Websiteinogen.com
301 Coromar Drive
Goleta, CA 93117
US
805 562 0500
About Inogen, Inc.

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Recent Insider Trades

NameTypeSharesPriceDate
Smith Kevin Raymond M-Exempt 28,334 2025-12-01
Smith Kevin Raymond F-InKind 13,817 $6.95 2025-12-01
Smith Kevin Raymond M-Exempt 28,334 2025-12-01
Ramade Gregoire M-Exempt 31,566 2025-12-01
Ramade Gregoire F-InKind 12,943 $6.95 2025-12-01

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms